Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: my first thesis

PROVIDER: PRJNA953602 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR24110856_1.fastq.gz	Fastqsanger.gz
	SRR24110856_2.fastq.gz	Fastqsanger.gz
	SRR24110857_1.fastq.gz	Fastqsanger.gz
	SRR24110857_2.fastq.gz	Fastqsanger.gz
	SRR24110858_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 48

Similar Datasets

GNPS_V229

Project description:Skin_associated_bacteria_from_Panamanian_frogs_(unpublished data) Please, use this data with confidentiality that it is an unpublished data for my thesis.

2015-11-11 | MSV000079374 | GNPS

GNPS_V229

Project description:Skin_associated_bacteria_from_Panamanian_frogs_(unpublished data) Please, use this data with confidentiality that it is an unpublished data for my thesis.

2015-11-11 | MSV000079375 | GNPS

Single-cell RNA sequencing distinctly characterizes the wide heterogeneity in pediatric mixed phenotype acute leukemia

Project description:We analyzed over 40,000 cells from nine pediatric MPAL BM samples to generate a single-cell transcriptomic landscape of B/Myeloid (B/My) and T/Myeloid (T/My) MPAL blasts and associated microenvironment cells. Cell clusters were identified using principal component analysis and uniform manifold approximation and projection (UMAP). Supervised differentially expressed gene (DEG) analysis was performed to identify B/My and T/My MPAL blast-specific signatures. MPAL sample transcriptome profiles were compared with normal BM stem and immune cells to identify MPAL-specific dysregulation. We have for the first time described the single-cell transcriptomic landscape of pediatric MPAL and have demonstrated that B/My and T/My MPAL have unique scRNA-seq profiles distinct from each other with expected overlap with AML and their respective ALL subtype.

2023-09-27 | GSE236351 | GEO

Proteomic analysis of chemical and genetic EZH2 inhibition in diffuse intrinsic pontine glioma cell lines

Project description:Diffuse Intrinsic Pontine Glioma (DIPG) is a rare and highly aggressive pediatric tumor. The average survival time after diagnosis is less than one year. Currently, there are no effective treatments. Characteristic of DIPG is a mutation in histone H3 which leads to a substitution of Lysine 27 to Methionine (H3K27M) which deregulates Polycomb Repressive Complex 2 (PRC2), including enzymatic activity of EZH2. Previous studies have shown that inhibition of EZH2 by chemical agents decreases DIPG cell proliferation and inhibits tumor growth in vivo. My thesis project aims to confirm that EZH2 could be a therapeutic target using chemical EZH2 inhibitors, small interfering RNAs and a CRISPR/Cas9 approach in a series of DIPG tumor cell lines and to determine underlying molecular mechanisms of action.

2022-04-01 | PXD017525 | Pride

MY-CLIP verification study

Project description:Comparison between BrdU-CLIP and MY-CLIP for HNRNPU, and MY-CLIP performance for HNRNPC

2020-03-31 | GSE138649 | GEO

Project description:my data

| PRJNA429333 | ENA

Project description:my desc

| PRJEB46976 | ENA

Project description:My Bacteria

| PRJNA1059236 | ENA

Project description:Pickle-MY

| PRJNA816670 | ENA